Bausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 02/14/24
Bausch + Lomb (BLCO) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 11/01/23
Bausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/25/23
Is the Options Market Predicting a Spike in Bausch + Lomb (BLCO) Stock?Zacks Investment Research • 09/19/23
Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization PlatformBusiness Wire • 04/13/23
Bausch + Lomb Appoints Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic PharmaceuticalsBusiness Wire • 04/12/23
New Bausch + Lomb Social Media Campaign Highlights What ‘Sights' Inspire AMD PatientsBusiness Wire • 02/07/23
Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb's VISUDYNE® (Verteporfin for Injection)Business Wire • 02/01/23
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22Business Wire • 01/23/23